Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: The al-Ándalus project
Author
Estevez-López, F.Guerrero-González, J.M.
Salazar-Tortosa, D.
Camiletti-Moirón, D.
Gavilán-Carrera, B.
Aparicio, V.A.
Acosta-Manzano, P.
Álvarez-Gallardo, I.C.
Segura-Jimenez, V.
Soriano-Maldonado, A.
Geenen, R.
Delgado-Fernández, M.
Martínez-González, L.J.
Ruiz, J.R.
Álvarez-Cubero, M.J.
Affiliation
Department of Ecology and Evolutionary Biology, University of ArizonaIssue Date
2021-12-07Keywords
5-hydroxytryptamine receptor 2A geneadrenoceptor alpha 1A gene
charged multivesicular body protein 1A gene
opioid receptor μ1 gene
sodium voltage-gated channel alpha subunit 9 gene
Metadata
Show full item recordPublisher
Oxford University PressCitation
Fernando Estévez-López, Juan M Guerrero-González, Diego Salazar-Tortosa, Daniel Camiletti-Moirón, Blanca Gavilán-Carrera, Virginia A Aparicio, Pedro Acosta-Manzano, Inmaculada C Álvarez-Gallardo, Víctor Segura-Jiménez, Alberto Soriano-Maldonado, Rinie Geenen, Manuel Delgado-Fernández, Luis J Martínez-González, Jonatan R Ruiz, María J Álvarez-Cubero, Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project, Rheumatology, Volume 61, Issue 8, August 2022, Pages 3180–3191, https://doi.org/10.1093/rheumatology/keab911Journal
Rheumatology (United Kingdom)Rights
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Objectives: It is widely acknowledged that the experience of pain is promoted by both genetic susceptibility and environmental factors such as engaging in physical activity (PA), and that pain-related cognitions are also important. Thus, the purpose of the present study was to test the association of 64 polymorphisms (34 candidate genes) and the gene-gene, gene-PA and gene-sedentary behaviour interactions with pain and pain-related cognitions in women with FM. Methods: Saliva samples from 274 women with FM [mean (s.d.) age 51.7 (7.7) years] were collected for extracting DNA. We measured PA and sedentary behaviour by accelerometers for a week, pain with algometry and questionnaires, and pain-related cognitions with questionnaires. To assess the robustness of the results, a meta-Analysis was also performed. Results: The rs6311 and rs6313 polymorphisms (5-hydroxytryptamine receptor 2A, HTR2A) were individually related to algometer scores. The interaction of rs4818 (catechol-O-methyltransferase, COMT) and rs1799971 (opioid receptor μ gene, OPRM1) was related to pain catastrophizing. Five gene-behaviour interactions were significant: The interactions of sedentary behaviour with rs1383914 (adrenoceptor alpha 1A, ADRA1A), rs6860 (charged multivesicular body protein 1A, CHMP1A), rs4680 (COMT), rs165599 (COMT) and rs12994338 (SCN9A) on bodily pain subscale of the Short Form 36. Furthermore, the meta-Analysis showed an association between rs4680 (COMT) and severity of FM symptoms (codominant model, P-value 0.032). Conclusion: The HTR2A gene (individually), COMT and OPRM1 gene-gene interaction, and the interactions of sedentary behaviour with ADRA1A, CHMP1A, COMT and SCN9A genes were associated with pain-related outcomes. Collectively, findings from the present study indicate a modest contribution of genetics and gene-sedentary behaviour interaction to pain and pain catastrophizing in women with FM. Future research should examine whether reducing sedentary behaviour is particularly beneficial for reducing pain in women with genetic susceptibility to pain. © 2021 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology.Note
Open access articleISSN
1462-0324PubMed ID
34875034Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1093/rheumatology/keab911
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/).